Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

Lignende værker

• The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
  af: Flores, Andrew J., et al.
  Udgivet: (2018)
• The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia
  af: Bartlett, Mitchell J., et al.
  Udgivet: (2020)
• Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model
  af: Bartlett, Mitchell J., et al.
  Udgivet: (2015)
• µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
  af: Bezard, Erwan, et al.
  Udgivet: (2020)
• Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia
  af: Bartlett, Mitchell J., et al.
  Udgivet: (2020)